Skip NavigationSkip to Content

NCI at Frederick Scientific Publications Advanced Search

Search

  1. NCI-F Publications

  2. Return to Quick Search
Search
  2. Year Published:

Your search returned 30 results.
User Information
Export Records
  1. 1.   Chronic Low-Level IFN-gamma Expression Disrupts Mitochondrial Complex I Activity in Renal Macrophages: An Early Mechanistic Driver of Lupus Nephritis Pathogenesis
  2. Bae, Heekyong R; Shin, Su-Kyung; Lee, Ji-Yoon; Ko, Yeo Jin; Kim, Suntae; Young,Howard; Kwon, Eun-Young
  3. International Journal of Molecular Sciences. 2024, Dec 25; 26(1):
  1. 2.   IFN-gamma and androgens disrupt mitochondrial function in murine myocytes
  2. Fenimore, John M; Springer, Danielle A; Romero, Maria E; Edmondson,Elijah; McVicar,Daniel; Yanpallewar, Sudhirkumar; Sanford,Michael; Spindel, Thea; Engle, Elizabeth; Meyer, Thomas J; Valencia,Julio; Young,Howard
  3. The Journal of Pathology. 2023, Apr 27;
  1. 3.   Homozygous variant p. Arg90His in NCF1 is associated with early-onset Interferonopathy: a case report
  2. Schnappauf, Oskar; Heale, Liane; Dissanayake, Dilan; Tsai, Wanxia L.; Gadina, Massimo; Leto, Thomas L.; Kastner, Daniel L.; Malech, Harry L.; Kuhns,Doug; Aksentijevich, Ivona; Laxer, Ronald M.
  3. Pediatric Rheumatology . 2021, Apr 23; 19(1):
  1. 4.   Reversing the Paradigm: Protein Kinase C as a Tumor Suppressor
  2. Newton, Alexandra C.; Brognard, John
  3. TRENDS IN PHARMACOLOGICAL SCIENCES. 2017, May; 38(5): 438-447.
  1. 5.   Polymorphisms in complement system genes and risk of non-Hodgkin lymphoma
  2. Bassig, B. A.; Zheng, T. Z.; Zhang, Y. W.; Berndt, S. I.; Holford, T. R.; Hosgood, H. D.; Hu, W.; Leaderer, B.; Yeager, M.; Menashe, I.; Boyle, P.; Xu, J.; Zou, K. Y.; Zhu, Y.; Chanock, S.; Rothman, N.; Lan, Q.
  3. Environmental and Molecular Mutagenesis. 2012, Mar; 53(2): 145-151.
  1. 6.   Ifih1 Gene Dose Effect Reveals MDA5-Mediated Chronic Type I IFN Gene Signature, Viral Resistance, and Accelerated Autoimmunity
  2. Crampton, S. P.; Deane, J. A.; Feigenbaum, L.; Boll, S.
  3. Journal of Immunology. 2012, Feb; 188(3): 1451-1459.
  1. 7.   CCR6/CCR10-mediated plasmacytoid dendritic cell recruitment to inflamed epithelia after instruction in lymphoid tissues
  2. Sisirak, V.; Vey, N.; Vanbervliet, B.; Duhen, T.; Puisieux, I.; Homey, B.; Bowman, E. P.; Trinchieri, G.; Dubois, B.; Kaiserlian, D.; Lira, S. A.; Puisieux, A.; Blay, J. Y.; Caux, C.; Bendriss-Vermare, N.
  3. Blood. 2011, Nov; 118(19): 5130-5140.
  1. 8.   CpG DNA as a vaccine adjuvant
  2. Bode, C.; Zhao, G.; Steinhagen, F.; Kinjo, T.; Klinman, D. M.
  3. Expert Review of Vaccines. 2011, Apr; 10(4): 499-511.
  1. 9.   Type I interferon: friend or foe?
  2. Trinchieri, G.
  3. Journal of Experimental Medicine. 2010, Sep; 207(10): 2053-2063.
  1. 10.   The Non-Muscle Myosin Heavy Chain 9 Gene (MYH9) Is Not Associated with Lupus Nephritis in African Americans
  2. Freedman, B. I.; Edberg, J. C.; Comeau, M. E.; Murea, M.; Bowden, D. W.; Divers, J.; Alarcon, G. S.; Brown, E. E.; McGwin, G.; Kopp, J. B.; Winkler, C. A.; Nelson, G. W.; Illei, G.; Petri, M.; Ramsey-Goldman, R.; Reveille, J. D.; Vila, L. M.; Langefeld, C. D.; Kimberly, R. P.; Grp, P. S.
  3. American Journal of Nephrology. 2010, Jul; 32(1): 66-72.
  1. 11.   Mechanisms of copy number variation and hybrid gene formation in the KIR immune gene complex
  2. Traherne, J. A.; Martin, M.; Ward, R.; Ohashi, M.; Pellett, F.; Gladman, D.; Middleton, D.; Carrington, M.; Trowsdale, J.
  3. Human Molecular Genetics. 2010, Mar; 19(5): 737-751.
  1. 12.   Clinical Use of Interferon-gamma
  2. Miller, C. H. T.; Maher, S. G.; Young, H. A.; Donnelly, R. P.
  3. Cytokine Therapies: Novel Approaches for Clinical Indications. 2009; 1182 : 69-79.
  1. 13.   Immunization with DNA topoisomerase I induces autoimmune responses but not scleroderma-like pathologies in mice
  2. Hu, P. Q.; Hurwitz, A. A.; Oppenheim, M. J.
  3. Journal of Rheumatology. 2007, Nov; 34(11): 2243-2252.
  1. 14.   A novel role of the interferon-inducible protein IFI16 as inducer of proinflammatory molecules in endothelial cells
  2. Caposio, P.; Gugliesi, F.; Zannetti, C.; Sponza, S.; Mondini, M.; Medico, E.; Hiscott, J.; Young, H. A.; Gribaudo, G.; Gariglio, M.; Landolfo, S.
  3. Journal of Biological Chemistry. 2007, Nov; 282(46):
  1. 15.   Control of toll-like receptor 7 expression is essential to restrict autoimmunity and dendritic cell proliferation
  2. Deane, J. A.; Pisitkun, P.; Barrett, R. S.; Feigenbaum, L.; Town, T.; Ward, J. M.; Flavell, R. A.; Boll, S.
  3. Immunity. 2007, Nov; 27(5): 801-810.
  1. 16.   cis sequence effects on gene expression
  2. Bergen, A. W.; Baccarelli, A.; McDaniel, T. K.; Kuhn, K.; Pfeiffer, R.; Kakol, J.; Bender, P.; Jacobs, K.; Packer, B.; Chanock, S. J.; Yeager, M.
  3. Bmc Genomics. 2007, Aug; 8
  1. 17.   Autoimmunity, spontaneous tumourigenesis, and IL-15 insufficiency in mice with a targeted disruption of the tumour suppressor gene FusI
  2. Ivanova, A. V.; Ivanov, S. V.; Pascal, V.; Lumsden, J. M.; Ward, J. M.; Morris, N.; Tessarolo, L.; Anderson, S. K.; Lerman, M. I.
  3. Journal of Pathology. 2007, Apr; 211(5): 591-601.
  1. 18.   HLA polymorphisms in African Americans with idiopathic inflammatory myopathy - Allelic profiles distinguish patients with different clinical phenotypes and myositis autoantibodies
  2. O'Hanlon, T. P.; Rider, L. G.; Mamyrova, G.; Targoff, I. N.; Arnett, F. C.; Reveille, J. D.; Carrington, M.; Gao, X. J.; Oddis, C. V.; Morel, P. A.; Malley, J. D.; Malley, K.; Shamim, E. A.; Chanock, S. J.; Foster, C. B.; Bunch, T.; Reed, A. M.; Love, L. A.; Miller, F. W.
  3. Arthritis and Rheumatism. 2006, Nov; 54(11): 3670-3681.
  1. 19.   A high-resolution HLA and SNP haplotype map for disease association studies in the extended human MHC
  2. de Bakker, P. I. W.; McVean, G.; Sabeti, P. C.; Miretti, M. M.; Green, T.; Marchini, J.; Ke, X. Y.; Monsuur, A. J.; Whittaker, P.; Delgado, M.; Morrison, J.; Richardson, A.; Walsh, E. C.; Gao, X. J.; Galver, L.; Hart, J.; Hafler, D. A.; Pericak-Vance, M.; Todd, J. A.; Daly, M. J.; Trowsdale, J.; Wijmenga, C.; Vyse, T. J.; Beck, S.; Murray, S. S.; Carrington, M.; Gregory, S.; Deloukas, P.; Rioux, J. D.
  3. Nature Genetics. 2006, Oct; 38(10): 1166-1172.
  1. 20.   The role of cytokine mRNA stability in the pathogenesis of autoimmune disease
  2. Seko, Y.; Cole, S.; Kasprzak, W.; Shapiro, B. A.; Ragheb, J. A.
  3. Autoimmunity Reviews. 2006, May; 5(5): 299-305.
  1. 21.   Immunogenetic risk and protective factors for the idiopathic inflammatory myopathies - Distinct HLA-A -B, -Cw,-DRB1, and-DQA1 allelic profiles distinguish European American patients with different myositis autoantibodies
  2. O'Hanlon, T. P.; Carrick, D. M.; Targoff, I. N.; Arnett, F. C.; Reveille, J. D.; Carrington, M.; Gao, A. J.; Oddis, C. V.; Morel, P. A.; Malley, J. D.; Malley, K.; Shamim, E. A.; Rider, L. G.; Chanock, S. J.; Foster, C. B.; Bunch, T.; Blackshear, P. J.; Plotz, P. H.; Love, L. A.; Miller, F. W.
  3. Medicine. 2006, Mar; 85(2): 111-127.
  1. 22.   Immunogenetic risk and protective factors for the idiopathic inflammatory myopathies - Distinct HLA-A, -B, -Cw,-DRB1 and -DQA1 allelic profiles and motifs define clinicopothologic groups in Caucasians
  2. O'Hanlon, T. P.; Carrick, D. M.; Arnett, F. C.; Reveille, J. D.; Carrington, M.; Gao, X. J.; Oddis, C. V.; Morel, P. A.; Malley, J. D.; Malley, K.; Dreyfuss, J.; Shamim, E. A.; Rider, L. G.; Chanock, S. J.; Foster, C. B.; Bunch, T.; Plotz, P. H.; Love, L. A.; Miller, F. W.
  3. Medicine. 2005, NOV; 84(6): 338-349.
  1. 23.   Autoantigens act as tissue-specific chemoattractants
  2. Oppenheim, J. J.; Dong, H. F.; Plotz, P.; Caspi, R. R.; Dykstra, M.; Pierce, S.; Martin, R.; Carlos, C.; Finn, O.; Koul, O.; Howard, O. M. Z.
  3. Journal of Leukocyte Biology. 2005, JUN; 77(6): 854-861.
  1. 24.   The interferon-inducible p200 family of proteins: a perspective on their roles in cell cycle regulation and differentiation
  2. Asefa, B.; Klarmann, K. D.; Copeland, N. G.; Gilbert, D. J.; Jenkins, N. A.; Keller, J. R.
  3. Blood Cells Molecules and Diseases. 2004, JAN-FEB; 32(1): 155-167.
  1. 25.   IFN-gamma polymorphisms (IFN-gamma+2109 and IFN-gamma+3810) are associated with severe hepatic fibrosis in human hepatic schistosomiasis (Schistosoma mansoni)
  2. Chevillard, C.; Moukoko, C. E.; Elwali, N.; Bream, J. H.; Kouriba, B.; Argiro, L.; Rahoud, S.; Mergani, A.; Henri, S.; Gaudart, J.; Mohamed-Ali, Q.; Young, H. A.; Dessein, A. J.
  3. Journal of Immunology. 2003 171(10): 5596-5601.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel